UK markets close in 8 hours 6 minutes

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.99-0.06 (-0.58%)
At close: 04:00PM EDT
10.91 -0.08 (-0.69%)
After hours: 07:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-28,061
-33,277
-45,738
-37,230
-25,469
Depreciation & amortisation
2,589
2,780
2,368
2,127
1,040
Deferred income taxes
-
-
0
164
0
Stock-based compensation
3,847
4,402
5,215
5,090
5,374
Change in working capital
-39,785
-33,370
30,525
-16,377
-32,121
Accounts receivable
-
-2,624
-1,813
5,343
-4,055
Accounts payable
-
-4,208
7,049
-4,354
1,257
Other working capital
-47,256
-60,973
-8,609
-48,622
-54,929
Other non-cash items
-436
-91
-30
-133
-69
Net cash provided by operating activities
-47,083
-59,932
-7,660
-45,896
-52,467
Cash flows from investing activities
Investments in property, plant and equipment
-173
-1,041
-949
-2,726
-2,462
Purchases of investments
-20,474
-48,395
0
-41,499
-59,317
Sales/maturities of investments
30,307
28,200
0
83,437
71,617
Net cash used for investing activities
9,660
-21,236
-949
39,212
9,838
Cash flows from financing activities
Common stock issued
19,729
6,922
57,101
9,624
30,998
Net cash used provided by (used for) financing activities
19,874
7,214
59,127
10,115
32,166
Net change in cash
-15,529
-79,129
47,328
8,176
-12,607
Cash at beginning of period
48,423
117,764
70,436
62,260
74,867
Cash at end of period
30,874
38,635
117,764
70,436
62,260
Free cash flow
Operating cash flow
-47,083
-59,932
-7,660
-45,896
-52,467
Capital expenditure
-173
-1,041
-949
-2,726
-2,462
Free cash flow
-47,256
-60,973
-8,609
-48,622
-54,929